Siglec-8 as mast cell selective target: developing paradigms amidst inconvenient truths
Crossref DOI link: https://doi.org/10.1007/s00210-017-1425-9
Published Online: 2017-09-14
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Molderings, Gerhard J.
License valid from 2017-09-14